| Application no. and date | 17169192.6 (espacenet) (Federated) (European Patent Register), 20091009 | | Patent/reg. no. and date | DK/EP 3228320, 20191218 | | Publication date | 20171011 | | Priority no. and date | DE 102008051834, 20081017, DE 102008053048, 20081024, DE 102009038210, 20090820 | | EP pub. no. and date |
EP 3228320 20171011 | | Effective date | | | Applicant/owner | Sanofi-Aventis Deutschland GmbH, Brüningstraße 50
65929 Frankfurt am Main, DE | | Applicant ref. no. | 1533363 | | Inventor | WERNER, Ulrich, Sanofi-Aventis Deutschland GmbH
c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE,
ROTTHÄUSER, Bärbel, Sanofi-Aventis Deutschland GmbH
c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE,
SMITH, Christopher, James, Sanofi-Aventis Deutschland GmbH
c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 38/26 (2006.01) , A61K 38/28 (2006.01) , A61P 5/50 (2006.01) | | Title | KOMBINATION AF ET INSULIN OG EN GLP-1-AGONIST | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
